Loading stock data…
CONMED Corporation (CNMD)
$46.27-3.05 (-6.18%)
Market OpenUpdated 12:06 PM EDT
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CONMED Corporation in the Healthcare sector is trading at $46.59 with a market capitalization of $1.5B. Wall Street consensus targets $45.50 (6 analysts), implying a -2.3% move over the next 12 months. The stock is currently 14% below its 52-week high of $54.12, remaining 15.0% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $343.49M↑ | $317.05M↓ | $373.20M↑ | $337.93M↓ | $342.35M |
| Gross Profit | $197.46M↑ | $183.45M↓ | $218.28M↑ | $166.12M↓ | $188.32M |
| Operating Income | $36.41M↑ | $25.41M↓ | $36.62M↑ | $11.88M↓ | $38.16M |
| Net Income | $23.07M↑ | $13.83M↓ | $16.74M↑ | $2.86M↓ | $21.42M |
Peer Comparison
JNJUNHPFE
Fundamentals
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.49B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.78
Beta
Defensive asset. Lower volatility than the S&P 500.
0.90
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.43%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.43%
Volume
Today's trading volume
76,336
Recent News
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
CONMED has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $51.11 per share while the index has gained 10.9%.
The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
Recently, CONMED Corporation was highlighted for its positioning in differentiated surgical platforms such as AirSeal, Buffalo Filter, and BioBrace, with these products benefiting from supportive regulatory trends and growing clinical adoption, while the company continues to face risks from tariffs and slower expansion in specific platforms like AirSeal. An interesting angle is that regulatory momentum around operating room air quality and clinician willingness to adopt newer biomaterials...